Hemofarm a.d.
{{Short description|Serbian pharmaceutical company}}
{{Infobox company
| name = Hemofarm
| logo = File:Hemofarm logo.gif
| logo_caption = Official logo
| image =
| image_caption =
| trading_name =
| native_name = Хемофарм
| native_name_lang = sr
| romanized_name =
| former type =
| type = Joint-stock company
| traded_as =
| industry = Pharmaceuticals
| genre =
| fate =
| predecessor =
| successor =
| foundation = {{Start date|1998|08|28|df=yes}} {{small|(current form)}}
{{Start date|1960}} {{small|(founded)}}
| founder =
| defunct =
| location_city = Beogradski put bb, Vršac
| location_country = Serbia
| key_people = Ronald Seeliger (CEO)
| products = Pharmaceuticals, Prescription drugs
| production =
| services =
| revenue = {{increase}} €337.37 million {{small|(2018)}}{{cite web|title=КОНСОЛИДОВАНИ БИЛАНС УСПЕХА (2018) - Хемофарм|url=http://pretraga3.apr.gov.rs/docRepo/download?xbcd=7100073619901&xrnd=FF635C0B1CFF20FD5E8D7BC999FF4C615B324252|website=apr.gov.rs|accessdate=28 September 2019|language=Serbian}}
| operating_income =
| net_income = {{increase}} €26.47 million {{small|(2018)}}
| assets = {{increase}} €436.09 million {{small|(2018)}}{{cite web|title=КОНСОЛИДОВАНИ БИЛАНС СТАЊА (2018) - Хемофарм|url=http://pretraga3.apr.gov.rs/docRepo/download?xbcd=7100073619895&xrnd=3CFE4B9EAC8EF0224AE3FC32BBB482D2EC886C12|website=apr.gov.rs|accessdate=28 September 2019}}
| equity = {{increase}} €296.34 million {{small|(2018)}}
| owner = STADA {{small|(100%)}}
| num_employees = 3,134 {{small|(2018)}}
| parent =
| divisions =
| subsid =
| homepage = {{URL|http://www.hemofarm.com/}}
| footnotes =
| intl =
| bodystyle =
}}
Hemofarm a.d. (full legal name: Hemofarm a.d. Farmaceutsko-hemijska industrija Vršac), a member of STADA Group, is a Serbian pharmaceutical company based in Vršac, Serbia. Founded in 1960, it is one of the largest domestic producers and exporters of medicines in Serbia. Hemofarm currently operates in more than 30 countries on 3 continents and has around 3,000 employees.
The core activity represents the manufacture of Rx and OTC medicines and products. The portfolio includes over 140 International Nonproprietary Names (INNs),https://www.who.int/teams/health-product-and-policy-standards/inn with about 280 forms and dosage forms.
History
Hemofarm was established on 1 June 1960 in Vršac. In 2003, it opened the first factory for the production of medicine in entity Republika Srpska, Bosnia and Herzegovina. As of 2003, Hemofarm consisted of 21 subsidiaries, 12 of which were located in Serbia and the rest in Montenegro.{{cite web|url=http://www.accessmylibrary.com/coms2/summary_0286-22517946_ITM|title=Bosnian Serb, Serbian premiers inaugurate pharmaceutical plant|accessdate=2008-10-02|date=February 21, 2003|publisher=Asia Africa Intelligence Wire}}
In 2004, the company acquired four other Serbian pharmaceutical companies, increasing its market share from 15% to 45%.[https://books.google.com/books?id=dduTMrBQxBsC Doing Business with Serbia] By Marat Terterov, Consultant Editor, Marat Terterov, Inc NetLibrary; Published by GMB Publishing Ltd, 2006; {{ISBN|1-905050-68-2}}, {{ISBN|978-1-905050-68-0}}. As of 2011, the company had a market share in terms of production and import of 30.7%.{{cite web|last1=Lazarević|first1=Igor|title=Konsolidacija farmaceutskog tržišta Srbije|url=https://www.scribd.com/doc/121448358/Konsolidacija-farmaceutskog-tr%C5%BEi%C5%A1ta-Srbije|website=scribd.com|accessdate=28 July 2014|language=Serbian}}
Hemofarm was bought by the German STADA Arzneimittel pharmaceutical group for 480 million euros in 2006.{{cite web|url=https://www.bloomberg.com/news/2013-01-10/stada-board-would-consider-high-takeover-offer.html|title=Stada Says Strength of Russian Unit May Attract Bids|publisher=Blommberg|date=11 January 2013|accessdate=9 April 2013}} Since 9 August 2009, Hemofarm has been a member of the German STADA Group.{{Citation needed|date=June 2022}}
In August 2016, Hemofarm bought the assets of a minor Serbian pharmaceutical company, "Ivančić i sinovi", for an undisclosed amount.{{cite news|last1=Popadić|first1=Jelena|title=Ko je kupio "Ivančić i sinove"|url=http://www.politika.rs/sr/clanak/364199/Ko-je-kupio-Ivancic-i-sinove|accessdate=13 March 2018|work=politika.rs|date=25 September 2016|language=Serbian}}
Research and development
Hemofarm’s R&D division was established in 1990, and it has been recognized by STADA as a competence center for development of new generic products not only for local and regional markets, but also for the whole STADA Group. An intensive development of products intended for registration and sale in the demanding European Union market started in 2007.{{Citation needed|date=April 2013}}
References
{{Reflist}}
External links
- {{Official website|http://www.hemofarm.com}}
- [https://www.stada.com/de/company/stada-worldwide/bosnia-herzegovina.html Official Stada group website]
Category:1960 establishments in Serbia
Category:2006 mergers and acquisitions
Category:Companies based in Vršac
Category:Pharmaceutical companies established in 1960
Category:Pharmaceutical companies of Serbia
{{Serbia-company-stub}}